Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.
Xuanyou JinEunwoo KimKi Young HuhInyoung HwangJoo-Youn ChoKyung-Sang YuSeung Hwan LeePublished in: Translational and clinical pharmacology (2020)
ClinicalTrials.gov Identifier: NCT03355014.
Keyphrases